Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_230_библиотеки_им_акад_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
13.10.2026
Размер:
2 Мб
Скачать
☆
141
СПИСОК ЛИТЕРАТУРЫ
1. Roger, V.L. Epidemiology of Heart Failure. A Contemporary Perspective/ V.L.
Roger//Circulation Research. - 2021.- N 128. -P. 1421–1434.
2. 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for
the Management of Heart Failure/ C.W. Yancy, M. Jessup, B. Bozkurt [et. al.]// Journal
of American College of Cardiology. - 2017. - N 70. - P.776‐803.
3. Paulus, W. J. / H2FPEF Score. At Last, a Properly Validated Diagnostic Algo-
rithm for Heart Failure with Preserved Ejection Fraction/ W. J. Paulus// Circulation. -
2018.-N 138. - P. 871–873.
4. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic
heart failure: Developed by the Task Force for the diagnosis and treatment of acute and
chronic heart failure of the European Society of Cardiology (ESC) With the special con-
tribution of the Heart Failure Association (HFA) of the ESC/ T.A. McDonagh, M. Met-
ra, M. Adamo [et. al.]//European Heart Journal. -2021. - N 42 (36). - P. 3599-3726.
5. Echocardiography study group of the Italian society of C. Speckle tracking
echocardiography: a new technique for assessing myocardial function/ S. Mondillo, M.
Galderisi, D. Mele [et. al.]// Journal of Ultrasound Medicine. - 2011.- N 30. - P.71–83.
6. Influence of aging on systolic left ventricular wall motion velocities along the
long and short axes in clinically normal patients determined by pulsed tissue Doppler
imaging/ Y. Onose, T. Oki, Y. Mishiro [et. al.]// Journal of American Society of Echo-
cardiography. - 1999. -N 12. - CP 921-926.
7. Two-dimensional strain-a novel software for real-time quantitative echocardio-
graphic assessment of myocardial function/ M. Leitman, P. Lysyansky, S. Sidenko [et.
al.]// Journal of American Society of Echocardiography. - 2004. - N 17. - P. 1021-1029.
8. Recovery of regional systolic and diastolic myocardial function after acute
myocardial infarction evaluated by two-dimensional speckle tracking echocardiography/
K. Wdowiak-Okrojek, P. Wejner-Mik, J. D. Kasprzak, P. Lipiec // Clinical Physiology
and Functional Imaging. - 2018. - N 39 (2). - P. 177-181.
https://t.me/med1917
142
9. New noninvasive method for assessment of left ventricular rotation: speckle
tracking echocardiography/ T. Helle-Valle, J. Crosby, T. Edvardsen [et.
Al.]// Circulation. - 2005.- N 112.- P. 3149–3156.
10. The impact of isometric handgrip testing on left ventricular twist mechanics/
R.B. Weiner, A.E. Weyman, J.H. Kim [et. al.] // Journal of Physiology. - 2012. -N
590(20). - P. 5141-50.
11. Simultaneous Beat-by-Beat Investigation of the Effects of the Valsalva Ma-
neuver on Left and Right Ventricular Filling and the Possible Mechanism [Электрон-
ный ресурс]/ Z. Wang, L. Yuan, T. Cao [et. al.]//Plos One. - 2013. - Режим доступа:
https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0053917
12. Bendopnea and risk of adverse clinical outcomes in ambulatory patients with
systolic heart failure/ J.T. Thibodeau, B.E. Jenny, J.O. Maduka [et. al.]// Am Heart
Journal. - 2017. - N 183(1). - P.102-107.
13. Baeza-Trinidad, R. Assessment of bendopnea impact on decompensated heart
failure// R. Baeza-Trinidad, J.D. Mosquera-Lozano, el L. Bikri// Eur J Heart Fail. -
2017. - N 19(1). - P.111-115.
14. Potter, E. Assessment of Left Ventricular Function by Echocardiography: The
Case for Routinely Adding Global Longitudinal Strain to Ejection Fraction/ E. Potter,
T.H. Marwick // JACC Cardiovascular Imaging. - 2018. - N 11. - P.260-274.
15. Left ventricular torsion. An expanding role in the analysis of myocardial dys-
function/ I.K. Russel, M.J.W. Götte, J.G. Bronzwaer [et. al.]// Journal of American Col-
lege of Cardiology Imagine. - 2009. - N 2. - P. 648–655.
16. Torsion of the left ventricle during the ejection phase in the intact dog/ T.Arts,
S. Meerbaum, R.S. Reneman, E. Corday// Cardiovasc Research. - 1984. - N 18. - P.
183–193.
17. Interaction of LV twist with arterial haemodynamics during localised, non-
metabolic hyperaemia with and without blood flow restriction/ A.C. Van Mil, A. Drane,
J. Pearson [et. al.]// Experimental Physiology. - 2016. - N 101. - P. 509–520.
https://t.me/med1917
143
18. Microvascular and lymphatic dysfunction in HFpEF and its associated
comorbidities/ I. Cuijpers, S.J. Simmonds, M. van Bilsen [et. al.]// Basic Research in
Cardiology. - 2020.- N 115(4). - P. 39.
19. Mosca, L. Sex/gender differences in cardiovascular disease prevention: what
a difference a decade makes/ L. Mosca, E. Barrett-Connor, N.K. Wenger // Circulation.
-2011.- N 124(19). - P. 2145-54.
20. Heart disease and stroke statistics 2015 update: a report from the American
Heart Circulation. / D. Mozaffarian, E.J. Benjamin, A.S. Go [et. al.]; American Heart
Association Statistics Committee and Stroke Statistics Subcommittee// Circulation. -
2015. - N 131(4). - P. 29-322.
21. Myocardial structure and function differ in systolic and diastolic HF/ I. Van
Heerebeek, A. Borbely, H.W. Niessen [et. al.]// Circulation. - 2006. - N 113. - P. 1966-
1973.
22. Left ventricular systolic performance, function, and contractility in patients
with diastolic heart failure/ C.F. Baicu, M.R. Zile, G.P. Aurigemma, W.H. Gaasch //
Circulation. - 2005. - N 111. - P. 2306-2312.
23. Right Heart Catheterization-Background, Physiological Basics, and Clinical
Implications/ G.M. Kubiak, A. Ciarka, M. Biniecka, P. Ceranowicz // Journal of Clini-
cal Medicine. - 2019. - N 8(9). - P.1331.
24. Validation of the 2016 ASE/EACVI Guideline for Diastolic Dysfunction in
Patients With Unexplained Dyspnea and a Preserved Left Ventricular Ejection Fraction/
A.A. van de Bovenkamp, V. Enait, F.S. de Man, T. P. F. [et. al.] // Journal of the Amer-
ican Heart Association. - 2021. - N10. - e021165.
25. On the search for the right definition of heart failure with preserved ejection
fraction/ A. Kapłon-Cieślicka, K. Kupczyńska, P. Dobrowolski [et. al.] // Cardiology
Journal. - 2020. - N 27(5). - P. 449-468.
26. Флакскампф, Ф. A. Практическая эхокардиография. Руководство по эхо-
кардиографической диагностике/ F.A. Flachskampf, перевод с немецкого В.А.
Сандриков. - Москва: МЕДпресс-информ, 2013. - 108 с.
https://t.me/med1917
144
27. Assessment of left and right ventricular systolic and diastolic synchronicity in
normal subjects by tissue Doppler echocardiography and the effects of age and heart
rate/ C.M. Yu, H. Lin, P.C. Ho, H. Yang // Echocardiography. - 2003. - N 20. - P. 19-
27.
28. Triplane tissue Doppler imaging: a novel three-dimensional imaging modality
that predicts reverse left ventricular remodelling after cardiac resynchronisation therapy/
N.R. Van de Veire, C.M. Yu, N. Ajmone-Marsan [et. al.]// Heart. 2008. - N 94(3). - P.
9.
29. Measurement of cardiac time intervals by Doppler tissue M-mode imaging of
the anterior mitral leaflet/ J. Kjaergaard, C. Hassager, J.K. Oh [et. al.]//Journal of Amer-
ican Society of Echocardiography. - 2005. - N 18(10). - P.1058-1065.
30. Usefulness of the myocardial performance index determined by tissue Dop-
pler imaging m-mode for predicting mortality in the general population/ T. Biering-
Sørensen, R. Mogelvang, S. Pedersen [et. al.]// American Journal of Cardiology. - 2011.
- N 107 (3). - P. 478-483.
31. Cardiac Time Intervals by Tissue Doppler Imaging M-Mode: Normal Values
and Association with Established Echocardiographic and Invasive Measures of Systolic
and Diastolic Function/ T. Biering-Sørensen, R. Mogelvang, M. Chantal de Knegt [et.
al.]// PLoS One. - 2016. - N 11(4). - P. 0153636.
32. Myocardial function defined by strain rate and strain during alterations in ino-
tropic states and heart rate/ F. Weidemann, F. Jamal, G.R. Sutherland [et. al.]// Ameri-
can Journal of Physiology and Heart Circulation Physiology. - 2002. - N 283(2). - P.
792-799.
33. Recommendations for chamber quantification: a report from the American
Society of Echocardiography’s Guidelines and Standards Committee and the Chamber
Quantification Writing Group, developed in conjunction with the European Association
of Echocardiography, a branch of the European Society of Cardiology/ R.M. Lang, M.
Bierig, R.B. Devereux [et. al.]//Journal of American Society of Echocardiography. -
2005. - N 18 (12). - P. 1440-1463.
https://t.me/med1917
145
34. Sanderson, J.E. Tissue Doppler imaging for predicting outcome in patients
with cardiovascular disease/ J.E. Sanderson, M. Wang, C.M. Yu. // Current Opinion in
Cardiology. - 2004. - N 19. - P. 458-463.
35. Chacon-Portillo, M.A. Imaging in heart failure with preserved ejection frac-
tion: insights into echocardiography and cardiac magnetic resonance imaging/ MA Cha-
con-Portillo, T. Acharya, R. Janardhanan //Reviews in Cardiovascular Medicine. -
2021. - N 22(1). - P.11-24.
36. Rademakers, F.E. Left Ventricular Myocardial Tagging / F.E. Rademakers, J.
Bogaret // International Journal of Cardiac Imaging. - 1997. - N 13. - P. 233-245.
37. Сережина, Е.К. Новые визуализирующие методики в диагностике сер-
дечной недостаточности с сохранной фракцией выброса/ Е.К. Сережина, А.Г. Об-
резан // Российский медицинский журнал «Медицинское обозрение». - 2019. - N
1(II). - C. 52-56.
38. How to diagnose diastolic heart failure: a consensus statement on the diagno-
sis of heart failure with normal left ventricular ejection fraction by the Heart Failure and
Echocardiography Associations of the European Society of Cardiology/ W.J. Paulus, C.
Tschöpe, J.E. Sanderson [et. al.]// European Heart Journal. - 2007. - N. 28. - P. 2539-
2550.
39. Role of left ventricular stiffness in heart failure with normal ejection fraction/
D. Westermann, M. Kasner, P. Steendijk [et. al.]// Circulation. - 2008.- N 117 (16). - P.
2051-2060.
40. Сережина, Е.К. Значимость эхокардиографической оценки деформации
миокарда левого предсердия в ранней диагностике сердечной недостаточности с
сохраненной фракцией выброса// Е.К. Сережина, А.Г. Обрезан// Кардиология. -
2021. - N 61(8). - C. 68-75.
41. Unlocking the mysteries of diastolic function deciphering the rosetta stone 10
years later/ S.J. Lester, A.J. Tajik, R.A. Nishimura [et. al.]// Journal of American Col-
lege of Cardiology. - 2008. -N 51. - P. 679-89.
https://t.me/med1917
146
42. LA Strain for Categorization of LV Diastolic Dysfunction/ A. Singh, K.
Addetia, F. Maffessanti, V. Mor-Avi [et. al.]// JACC Cardiovascular Imaging. - 2017. -
N 10(7). - P. 735-743.
43. Blum, M. Variability of Myocardial Strain During Isometric Exercise in Sub-
jects With and Without Heart Failure/ M. Blum, D. Hashemi, L.A. Motzkus [et. al.].
//Frontiers in cardiovascular medicine. - 2020. - N 7. - P. 111.
44. Saldaña, G. J. Influence of repetitions on the Valsalva maneuver/ G.J. Salda-
ña, L.A. Torremocha, D. Milner // Clinical Neurophysiology Practice. - 2020.- N 5. - P.
104-111.
45. Zema, M. J. Diagnosing Heart Failure by the Valsalva Maneuver: Isn't it Fi-
nally Time? / M. J. Zema// JACC: Heart Failure. - 2018. - N 6(11). - P.969-971.
46. Usefulness of Noninvasively Measured Pulse Amplitude Changes During the
Valsalva Maneuver to Identify Hospitalized Heart Failure Patients at Risk of 30-Day
Heart Failure Events (from the PRESSURE-HF Study)/ N.A. Gilotra, B.L. Wanamaker,
H. Rahim [et. al.] // American Journal of Cardiology. - 2020. - N 125(6). - P. 916-923.
47. Clinical examination and the Valsalva maneuver in heart failure/ G. E. Lini-
ado, M. A. Beck, G. M. Gimeno [et. al.] // Medicina (B Aires). - 2018. - N 78(3). -
P.163-170.
48. Characterization of a novel symptom of advanced heart failure: bendopnea/
J.T. Thibodeau, A.T. Turer, S.K. Gualano [et. al.]// JACC Heart Failure. - 2014. - N
2(1). - P. 24-31.
49. Clinical significance of bendopnea in heart failure—Systematic review and
meta-analysis/ R. Pranata, E. Yonas, V. Chintya [et. al.]// Indian Heart Journal. - 2019. -
N 71 (3). - P. 277-283.
50. Characterization of a novel symptom of advanced heart failure: bendopnea/
J.T. Thibodeau, A.T. Turer, S.K. Gualano, [et. al.]// Journals of the American College
of Cardiollogy Heart Failure. - 2014. - N.2 (1). - P. 24-31
51. Bendopnea: Association With Echocardiographic Features and Clinical Out-
comes in Elderly Patients With Chronic Heart Failure/ V.N. Larina, B.Ya. Bart, I.I.
Chukaeva [et. al.]// Kardiologiia. - 2018. - N 58(12). - P. 36-44.
https://t.me/med1917
147
52. Сережина, Е.К. Эффективность пробы с наклоном корпуса вперед
(bending test) и спектральной следящей эхокардиографии в диагностике сердечной
недостаточности с сохранённой фракцией выброса/ Е.К. Сережина, А.Г. Обрезан//
Кардиология: Новости. Мнения. Обучение. - 2022. - N. 28(1). - С. 22-28.
53. Li, J. Additional Diagnostic Value of Growth Differentiation Factor-15
(GDF-15) to N-Terminal B-Type Natriuretic Peptide (NT-proBNP) in Patients with Dif-
ferent Stages of Heart Failure/ J. Li, Y. Cui, A. Huang // Medical Science Monitor. -
2018. - N 24. - P. 4992-4999.
54. Sinning, C. Biomarkers for characterization of heart failure - Distinction of
heart failure with preserved and reduced ejection fraction// C. Sinning, T. Kempf, M.
Schwarzl// International Journal of Cardiology. - 2017. - N 227. - P. 272-277.
55. Сережина Е.К. Биомаркеры повреждения и ремоделирования миокарда в
диагностике сердечной недостаточности с сохранной фракцией выброса/ Сережи-
на Е.К., А.Г. Обрезан // Российский медицинский журнал «Медицинское обозре-
ние». - 2019. - N 3(I). - С. 23-26.
56. Rezar, J. Heart-Type Fatty Acid-Binding Protein (H-FABP) and its Role as a
Biomarker in Heart Failure: What Do We Know So Far? / J. Rezar, D.Gschwandtner ,
T.K. Felder // Journal of Clinical Medicine. - 2020. - N 9(1). - P. 164.
57. Сережина, Е.К. Новые биомаркеры повреждения, воспаления и ремоде-
лирования в дифференциальной диагностике типов сердечной недостаточности/
Е.К. Сережина, А.Г. Обрезан //Российский кардиологический журнал. - 2021. -
Т.26,№1. - С. 166-171.
58. Kutsuzawa, D. Ongoing myocardial damage in patients with heart failure and
preserved ejection fraction/ D. Kutsuzawa, T. Arimoto, T. Watanabe// Journal of Cardi-
ology. - 2012. - N 60. - P. 454–461.
59. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary
embolism developed in collaboration with the European Respiratory Society (ERS)/
S.V. Konstantinides, G. Meyer, C. Becattini [et. al.] // European Heart Journal. - 2019. -
N 41(4). - P. 1–61.
https://t.me/med1917
148
60. Wong, L.L. Combining Circulating MicroRNA and NT-proBNP to Detect
and Categorize Heart Failure Subtypes/ L.L. Wong, R. Zou, L. Zhou [et. al.] //Journal of
the American College of Cardiology. - 2019. N. 73(11). - P. 1300–1313.
61. Circulating microRNAs as novel biomarkers for heart failure/ F. Chen, J.
Yang, Y. Li [et. al.]// Hellenic J. Cardiol. - 2018. - N 59. - P. 209–214.
62. Combined use of circulating miR-133a and NT-proBNP improves heart fail-
ure diagnostic accuracy in elderly patients/ M. Guo, J. Luo, J. Zhao [et. al.]// Medical
Science Monitor. - 2018. - N 24. - P. 8840–8848.
63. Potential novel biomarkers of cardiovascular dysfunction and disease: cardio-
trophin-1, adipokines and galectin-3/ S. Hogas, S.C. Bilha, D. Branisteanu [et. al.]// Ar-
chives of Medical Science. - 2017. -N 4. - P. 897–913.
64. Heart disease and stroke statistics/ D. Mozaffarian, E. Benjamin, A. Go
[et.al.] //Circulation. - 2015. - N 131(4). - P. 29-322.
65. Postmenopausal status and early menopause as independent risk factors for
cardiovascular disease: a meta-analysis/ F. Atsma, M. Bartelink, D.E. Grobbee, Y.T.
van der Schouw // Menopause. - 2006. - N 13(2). - P. 265–279.
66. Menopause and the risk of coronary heart disease in women/ G.A. Colditz,
W.C. Willett, M.J. Stampfer, B. Rosner [et. al.]// New England Journal of Medicine. -
1987.- N 316(18). - P. 1105–1110.
67. Сережина, Е.К. Влияние половозрастных гормональных изменений на
формирование и развитие сердечной недостаточности/ Е.К. Сережина, А.Г. Обре-
зан// Российский кардиологический журнал. - 2020. - N 25(6). - C. 3710.
68. Age-related left ventricular remodeling and associated risk for cardiovascular
outcomes: the Multi-Ethnic Study of Atherosclerosis/ S. Cheng, V.R. Fernandes, D.A.
Bluemke [et. al.]//Circulation Cardiovascular Imaging. - 2009. - N 2. - P. 191–198.
69. Krumholz, H.M. Sex differences in cardiac adaptation to isolated systolic hy-
pertension/ H.M. Krumholz, M. Larson, D. Levy // American Journal of Cardiology. -
1993. - N 72. - P. 310–313.
https://t.me/med1917
149
70. Sex-specific cardiovascular structure and function in heart failure with pre-
served ejection fraction/ M. Gori, C.S. Lam, D.K. Gupta [et. al.]// European Journal of
Heart Failure. - 2014. - N 16. - P. 535–42.
71. Lakatta, E.G. Arterial and cardiac aging: major shareholders in cardiovascular
disease enterprises: Part I: aging arteries: a “set up” for vascular disease/ E.G. Lakatta,
D. Levy // Circulation. - 2003. - N 107. - P. 139–46.
72. Women have lower tonic autonomic support of arterial blood pressure and
less effective baroreflex buffering than men/ D.D. Christou, P.P. Jones, J. Jordan [et.
al.]// Circulation. - 2005. - N 111. - P. 494–498.
73. Effects of age and gender on autonomic control of blood pressure dynamics/
S. Barnett, R. Morin, D. Kiely [et. al.]// Hypertension. - 1999. - N 33. - P. 1195–1200.
74. Mitchell, G.F. Hemodynamics of increased pulse pressure in older women in
the community-based Age, Gene/Environment Susceptibility-Reykjavik Study/ G.F.
Mitchell, V. Gudnason, L. J. Launer// Hypertension. - 2008. - N 51. - P. 1123–1128.
75. Janowitz, W.R. Differences in prevalence and extent of coronary artery calci-
um detected by ultrafast computed tomography in asymptomatic men and women/ W.R.
Janowitz, A.S. Agatston, G. Kaplan// American Journal of Cardiology. - 1993. - N 72. -
P. 247–254.
76. Prevalence and determinants of carotid atherosclerosis in a general popula-
tion/ P. Prati, D. Vanuzzo, M. Casaroli [et. al.]//Stroke. - 1992. - N 23. - P. 1705–1711.
77. Sex differences in patients with asymptomatic carotid atherosclerotic plaque:
in vivo 3. 0-T magnetic resonance study/ H. Ota , M.J. Reeves, D.C. Zhu [et.
al.]// Stroke. - 2010. - N 41. - P. 1630–5.
78. Incident Cardiovascular Disease in Post-Menopausal Women/ D. Zhao, E.
Guallar, P. Ouyang [et. al.] // Journal of American College of Cardiology. - 2018. - N
71(22). - P. 2555-2566.
79. Estrogen induces nitric oxide production via nitric oxide synthase activation
in endothelial cells/ E. Nevzati, M. Shafighi, K.D. Bakhtian [et. al.] // Acta Neurochi-
rurgica Supplement. - 2015. - N 120. - P. 141-145.
https://t.me/med1917
150
80. Neurovascular Events After Subarachnoid Hemorrhage/ J. Fandino, S. Mar-
bacher, A-R. Fathi [et. al.] //Springer International Publishing. - 2015. - N.120 - P. 39–
46.
81. Transcriptional regulation of vascular endothelial growth factor by estradiol
and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors
alpha and beta/ H. Buteau-Lozano, M. Ancelin, B. Lardeux [et. al.] // Cancer Research.
- 2002.- N 1; 62(17). - P. 4977-4984.
82. Barnabas, O. Role of estrogen in angiogenesis in cardiovascular diseases/ O.
Barnabas, H. Wang, X-M. Gao // Journal of Geriatric Cardiology. - 2013. - N 10. - P.
377–382.
83. Natriuretic peptides (BNP and NT-proBNP): measurement and relevance in
heart failure/ A. Palazzuoli, M. Gallotta, I. Quatrini, R. Nuti // Vascular Health Risk
Managing. - 2010. - N 6. -P. 411–418.
84. Lam, CSP. Influence of Sex and Hormone Status on Circulating natriuretic
Peptides/ CSP. Lam, S. Cheng, K. Choong //Journal of American College of Cardiolo-
gy. - 2011. - N 58. - P. 618–626.
85. Yasui, T. Association of N-Terminal pro B-type natriuretic peptide and sex
hormone-binding globulin in non-obese peri- and postmenopausal women/ T. Yasui, S.
Matsui, A. Saijo// Clinica Chimica Acta. - 2010. - N 411. - P. 280–284.
86. Chang, A.Y. Associations Among Androgens, Estrogens and Natriuretic Pep-
tides in Young Women/ A.Y. Chang, S.M. Abdullah, T. Jain // Journal of American
College of Cardiology. - 2007. - N 49. - P. 109–116.
87. Increase in circulating levels of cardiac natriuretic peptides after hormone re-
placement therapy in postmenopausal women/ S. Maffei, S. Del Ry, C. Prontera, A.
Clerico // Clinical Science (London). - 2001. - N 101. - P. 447–453.
88. Sex steroids, sex hormone-binding globulin and levels of N-terminal pro-
brain natriuretic peptide in postmenopausal women/ M. Glisic, L.Z. Rojas, E. Asllanaj,
K.G. Vargas [et. al.] // International Journal of Cardiology. - 2018.- N.15; 261.-P.189-
195.
https://t.me/med1917